The methylation profiling of the CDH13 promoter in the HYPEST/CADCZ (HYPertension in ESTonia/Coronary Artery Disease in Czech) study sample (n = 358) resulted in the methylation levels of 46 CpG sites/units within 1,162 bp of its CpG island and flanking 361 bp 5′ upstream region (Fig. 1, Figure S3). Here, CDH13 is linked to coronary artery disorder.